Thoma Bravo’s Investment in Bluesight for Acquisition of Medacist

Kirkland & Ellis LLP served as legal counsel for Thoma Bravo in the transaction.A leading software investment firm,Thoma Bravo announced its controlling investment in Bluesight, the Medication Intelligence™…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here